514 related articles for article (PubMed ID: 20067840)
1. Mitochondrial medicine for neurodegenerative diseases.
Du H; Yan SS
Int J Biochem Cell Biol; 2010 May; 42(5):560-72. PubMed ID: 20067840
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial medicine for aging and neurodegenerative diseases.
Reddy PH
Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
[TBL] [Abstract][Full Text] [Related]
3. Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders.
Rahman MM; Tumpa MAA; Rahaman MS; Islam F; Sutradhar PR; Ahmed M; Alghamdi BS; Hafeez A; Alexiou A; Perveen A; Ashraf GM
Curr Neuropharmacol; 2023; 21(5):1081-1099. PubMed ID: 36927428
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
5. Behavioral and quantitative mitochondrial proteome analyses of the effects of simvastatin: implications for models of neural degeneration.
Pienaar IS; Schallert T; Hattingh S; Daniels WM
J Neural Transm (Vienna); 2009 Jul; 116(7):791-806. PubMed ID: 19504041
[TBL] [Abstract][Full Text] [Related]
6. Neuronal oscillations: A physiological correlate for targeting mitochondrial dysfunction in neurodegenerative diseases?
Chan F; Lax NZ; Davies CH; Turnbull DM; Cunningham MO
Neuropharmacology; 2016 Mar; 102():48-58. PubMed ID: 26518370
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial medicine: pharmacological targeting of mitochondria in disease.
Armstrong JS
Br J Pharmacol; 2007 Aug; 151(8):1154-65. PubMed ID: 17519949
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Biology and Neurological Diseases.
Arun S; Liu L; Donmez G
Curr Neuropharmacol; 2016; 14(2):143-54. PubMed ID: 26903445
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration.
Morán M; Moreno-Lastres D; Marín-Buera L; Arenas J; Martín MA; Ugalde C
Free Radic Biol Med; 2012 Aug; 53(3):595-609. PubMed ID: 22595027
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
12. C
Gonchar OO; Maznychenko AV; Klyuchko OM; Mankovska IM; Butowska K; Borowik A; Piosik J; Sokolowska I
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064070
[TBL] [Abstract][Full Text] [Related]
13. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration.
Cassarino DS; Bennett JP
Brain Res Brain Res Rev; 1999 Jan; 29(1):1-25. PubMed ID: 9974149
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons.
El-Mir MY; Detaille D; R-Villanueva G; Delgado-Esteban M; Guigas B; Attia S; Fontaine E; Almeida A; Leverve X
J Mol Neurosci; 2008; 34(1):77-87. PubMed ID: 18040888
[TBL] [Abstract][Full Text] [Related]
15. Protective role of melatonin in mitochondrial dysfunction and related disorders.
Paradies G; Paradies V; Ruggiero FM; Petrosillo G
Arch Toxicol; 2015 Jun; 89(6):923-39. PubMed ID: 25690732
[TBL] [Abstract][Full Text] [Related]
16. Perspectives of drug-based neuroprotection targeting mitochondria.
Procaccio V; Bris C; Chao de la Barca JM; Oca F; Chevrollier A; Amati-Bonneau P; Bonneau D; Reynier P
Rev Neurol (Paris); 2014 May; 170(5):390-400. PubMed ID: 24792485
[TBL] [Abstract][Full Text] [Related]
17. An overview of the pathophysiology of neurodegenerative disorders.
Willner C
Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272
[No Abstract] [Full Text] [Related]
18. Oxidative stress treatment for clinical trials in neurodegenerative diseases.
Ienco EC; LoGerfo A; Carlesi C; Orsucci D; Ricci G; Mancuso M; Siciliano G
J Alzheimers Dis; 2011; 24 Suppl 2():111-26. PubMed ID: 21422516
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.
Keating DJ
J Neurochem; 2008 Jan; 104(2):298-305. PubMed ID: 17961149
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.
Burchell VS; Gandhi S; Deas E; Wood NW; Abramov AY; Plun-Favreau H
Expert Opin Ther Targets; 2010 Apr; 14(4):369-85. PubMed ID: 20184395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
